Discover

PFS
Provident Financial Services, Inc.
23.06
600 x 23.05
400 x 23.06
bid
ask
-
0.09
0.39%
500 @ 07:30 PM
23.06 +0.00 (0.01%)
Ytd16.76%
1y13.48%
22.79
day range
23.10
17.77
52 week range
25.28
Open23.09Prev Close23.15Low22.79High23.10Mkt Cap3.01B
Vol1.94MAvg Vol938.46KEPS2.40P/E9.61Forward P/E8.87
Beta0.77Short Ratio6.58Inst. Own77.44%Dividend0.96Div Yield4.15
Ex Div Date08-14Earning10-2950-d Avg23.94200-d Avg22.291yr Est27.92

PFS News

RPX Gold Expands Gold Mineralization Beyond the PEA Open Pit and Underground Mine in Support of the Planned PFS
businesswire.com
RPX Gold Expands Gold Mineralization Beyond the PEA Open Pit and Underground Mine in Support of the

TORONTO--(BUSINESS WIRE)---- $RPX.V #Canada--RPX Gold Inc. (“RPX Gold” or the “Company”) (TSXV: RPX)

Johnson & Johnson's RYBREVANT® (amivantamab-vmjw) plus chemotherapy delivers longest reported median overall survival in EGFR exon 20 insertion mutation-positive lung cancer
gurufocus.com
Johnson & Johnson's RYBREVANT® (amivantamab-vmjw) plus chemotherapy delivers longest reported median

Johnson and Johnson's RYBREVANTÂ (amivantamab-vmjw) plus chemotherapy delivers longest reported medi

ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in DESTIN
gurufocus.com
ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 m

Positive results from the DESTINY-Lung04 Phase III trial showed AstraZeneca and Daiichi Sankyo's ENH

Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median Progression-Free Survival Benefit in REZILIENT3 Phase 3 Trial in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
gurufocus.com
Zipalertinib Plus Chemotherapy Demonstrates 6-Month Median Progression-Free Survival Benefit in REZI

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Cullinan Therapeutics, Inc. (Nasdaq: CGEM)

REGN INVESTOR DEADLINE TOMORROW: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
gurufocus.com
REGN INVESTOR DEADLINE TOMORROW: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses H

REGN INVESTOR DEADLINE TOMORROW: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses H

Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso's HARMONi-2 Study Condu
gurufocus.com
Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Com

Summit Therapeutics Inc. (NASDAQ: SMMT) today noted that its partner Akeso Inc. [url="]announced[/ur

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines - REGN
gurufocus.com
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Ph

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Ph

Inhibrx's INBRX-106 Nearly Doubles Response Rate and Achieves Interim Median PFS of 9.6 months in Phase 2 HNSCC Study
prnewswire.com
Inhibrx's INBRX-106 Nearly Doubles Response Rate and Achieves Interim Median PFS of 9.6 months in Ph

First OX40 agonist to demonstrate clinical benefit in a randomized study INBRX-106 plus pembrolizuma

Wallbridge Reports Results from 2026 Fenelon PFS Metallurgical Drilling Program
globenewswire.com
Wallbridge Reports Results from 2026 Fenelon PFS Metallurgical Drilling Program

TORONTO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Wallbridge Mining Company Limited (TSX: WM, OTCQB: WLBMF

Provident Financial (PFS) Upgraded to Buy: Here's Why
zacks.com
Provident Financial (PFS) Upgraded to Buy: Here's Why

Provident Financial (PFS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism ab

Regeneron Pharmaceuticals, Inc. (REGN) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before September 14, 2026 Lead Plaintiff Deadline
gurufocus.com
Regeneron Pharmaceuticals, Inc. (REGN) Investors: Securities Fraud Class Action Filed, Contact Hagen

Regeneron Pharmaceuticals, Inc. (REGN) Investors: Securities Fraud Class Action Filed, Contact Hagen

Ivonescimab Plus Chemotherapy Global Phase III HARMONi Primary Analysis Results Published in The Lancet Oncology
gurufocus.com
Ivonescimab Plus Chemotherapy Global Phase III HARMONi Primary Analysis Results Published in The Lan

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the publication of primary analysis results

Provident Financial Services, Inc. Announces Pricing of Subordinated Notes Offering
globenewswire.com
Provident Financial Services, Inc. Announces Pricing of Subordinated Notes Offering

ISELIN, N.J., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE:PFS) (the “

REGN Stockholders Interested in Leading the Class Action Against Regeneron Pharmaceuticals, Inc. Should Contact Robbins LLP for Information About Recovering Their Losses
gurufocus.com
REGN Stockholders Interested in Leading the Class Action Against Regeneron Pharmaceuticals, Inc. Sho

REGN Stockholders Interested in Leading the Class Action Against Regeneron Pharmaceuticals, Inc. Sho

AstraZeneca Reports Positive Lung Cancer Trials Amid Pipeline Setback
gurufocus.com
AstraZeneca Reports Positive Lung Cancer Trials Amid Pipeline Setback

AstraZeneca (AZN) is trading relatively stable after announcing two encouraging Phase III updates fo

Doubleview Gold Corp. Pursues Strategic Government Engagement Following US$400M U.S. Dept of War Scandium Funding Initiative
gurufocus.com
Doubleview Gold Corp. Pursues Strategic Government Engagement Following US$400M U.S. Dept of War Sca

Vancouver, BC, Aug 12, 2026 - (ACN Newswire) - Doubleview Gold Corp. (TSXV: DBG) (OTCQX: DBLVF) ("Do

3 Savings & Loan Stocks Worth Picking on Improving Industry Prospects
zacks.com
3 Savings & Loan Stocks Worth Picking on Improving Industry Prospects

WSFS, PFS and SMBC within the Zacks Savings and Loan Industry will gain from improving loan demand.

Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α-biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal
gurufocus.com
Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2α

Innovent Announces First Patient Dosed in Pivotal Registrational Study of IBI363/TAK-928 (PD-1/IL-2Î

Provident Financial (PFS) is a Great Momentum Stock: Should You Buy?
zacks.com
Provident Financial (PFS) is a Great Momentum Stock: Should You Buy?

Does Provident Financial (PFS) have what it takes to be a top stock pick for momentum investors? Let

Gilead Sciences Inc (GILD) (Q2 2026) Earnings Call Highlights: PrEP Sales Double to $1B, HIV Growth Accelerates, and Strategic Pipeline Advances
gurufocus.com
Gilead Sciences Inc (GILD) (Q2 2026) Earnings Call Highlights: PrEP Sales Double to $1B, HIV Growth

Total Product Sales (excluding Veklury): $7.6 billion, up 10% year-over-year.Total Product Sales (in

benzinga.com
Keefe, Bruyette & Woods Reiterates Outperform on Provident Finl Servs, Raises Price Target to $28

Keefe, Bruyette & Woods analyst Timothy Switzer reiterates Provident Finl Servs (NYSE:PFS) wi

benzinga.com
Piper Sandler Reiterates Overweight on Provident Finl Servs, Raises Price Target to $29

Piper Sandler analyst Manuel Navas reiterates Provident Finl Servs (NYSE:PFS) with a Overweight a

benzinga.com
Provident Finl Servs Q2 EPS $0.60 Beats $0.56 Estimate, Sales $202.680M Miss $206.371M Estimate

Provident Finl Servs (NYSE:PFS) reported quarterly earnings of $0.60 per share which beat the analys

benzinga.com
Raymond James Maintains Strong Buy on Provident Finl Servs, Raises Price Target to $27

Raymond James analyst Steve Moss maintains Provident Finl Servs (NYSE:PFS) with a Strong Buy and

benzinga.com
Provident Financial Services Appoints Adriano Duarte CFO, Effective July 1

Provident Bank, a leading New Jersey-based financial institution, announced today the appointment of

benzinga.com
Stephens & Co. Initiates Coverage On Provident Finl Servs with Equal-Weight Rating, Announces Price

Stephens & Co. analyst Matt Breese initiates coverage on Provident Finl Servs (NYSE:PFS) with

benzinga.com
Keefe, Bruyette & Woods Maintains Outperform on Provident Finl Servs, Raises Price Target to $26

Keefe, Bruyette & Woods analyst Timothy Switzer maintains Provident Finl Servs (NYSE:PFS) wit

Full Transcript: Provident Finl Servs Q1 2026 Earnings Call
benzinga.com
Full Transcript: Provident Finl Servs Q1 2026 Earnings Call

benzinga.com
Provident Finl Servs Q1 EPS $0.61 Beats $0.55 Estimate, Sales $225.196M Beat $208.384M Estimate

Provident Finl Servs (NYSE:PFS) reported quarterly earnings of $0.61 per share which beat the analys

Earnings Scheduled For April 29, 2026
benzinga.com
Earnings Scheduled For April 29, 2026

benzinga.com
DA Davidson Initiates Coverage On Provident Finl Servs with Neutral Rating, Announces Price Target o

DA Davidson analyst Jake Civiello initiates coverage on Provident Finl Servs (NYSE:PFS) with a Ne

benzinga.com
Keefe, Bruyette & Woods Maintains Outperform on Provident Finl Servs, Raises Price Target to $25

Keefe, Bruyette & Woods analyst Timothy Switzer maintains Provident Finl Servs (NYSE:PFS) wit

benzinga.com
Provident Finl Servs Q4 EPS $0.64 Beats $0.56 Estimate, Sales $197.411M Miss $207.587M Estimate

Provident Finl Servs (NYSE:PFS) reported quarterly earnings of $0.64 per share which beat the analys

Earnings Scheduled For January 27, 2026
benzinga.com
Earnings Scheduled For January 27, 2026

Earnings Volatility Watch: These 10 Stocks Could Swing 30% Or More This Week
benzinga.com
Earnings Volatility Watch: These 10 Stocks Could Swing 30% Or More This Week

Options markets are pricing in post-earnings swings of up to 50% this week, with regional banks in f

Earnings Scheduled For October 29, 2025
benzinga.com
Earnings Scheduled For October 29, 2025

benzinga.com
Earnings Scheduled For July 24, 2025

benzinga.com
Earnings Scheduled For April 24, 2025

benzinga.com
Earnings Scheduled For January 28, 2025

benzinga.com
Earnings Scheduled For April 18, 2024

Companies Reporting Before The Bell • Addex Therapeutics (NASDAQ:ADXN) is estimated to report earni

benzinga.com
Real Estate, Regional Bank Stocks Tank, Energy Cushions The Blow: March Inflation Rates Shake Up Sec

Inflation unexpectedly surges, shattering hopes for Fed rate cuts & sending stocks down. Core in

benzinga.com
Earnings Scheduled For January 25, 2024

Companies Reporting Before The Bell • Nokia (NYSE:NOK) is projected to report quarterly earnings at

benzinga.com
Exceeding Expectations: German American Bancorp Achieves Strong Performance and Rewards Investors

benzinga.com
Earnings Scheduled For October 26, 2023

Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnin

benzinga.com
Earnings Scheduled For July 27, 2023

Companies Reporting Before The Bell • SES AI (NYSE:SES) is projected to report quarterly earnings a

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  On Thursday, 498 companies reached new 52-week lows.

benzinga.com
Earnings Scheduled For April 27, 2023

Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its f

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 345 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  Tuesday's session saw 286 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Monday

  On Monday, 141 companies reached new 52-week lows.